Showing results (21-30 of 1,410) with videos related to

Sort By:
Pageof 141
Nature Reviews. Drug Discovery|February 28, 2009
Molecular targets for cancer chemopreventionWilliam N William, John V Heymach, Edward S Kim, et al.
Oncoimmunology|July 9, 2015
The mutually regulatory loop of epithelial-mesenchymal transition and immunosuppression in cancer progressionLimo Chen, John V Heymach, F Xiao-Feng Qin, et al.
Translational Lung Cancer Research|February 22, 2019
Stereotactic ablative body radiation for oligometastatic and oligoprogressive diseaseMatthew S Ning, Daniel R Gomez, John V Heymach, et al.
Microvascular Research|April 29, 2008
Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cellsDhara N Amin, Diane R Bielenberg, Eugene Lifshits, et al.
NPJ Precision Oncology|January 11, 2023
Antibody-drug conjugates in lung cancer: dawn of a new era?Niamh Coleman, Timothy A Yap, John V Heymach, et al.
Toxicologic Pathology|March 28, 2014
Quantitative evaluation of drug-induced microvascular constriction in mice kidney using a novel tool for 3D geometrical analysis of ex vivo organ vasculatureYuval Ramot, Raul Brauner, Kongbin Kang, et al.
Nature Reviews. Clinical Oncology|August 17, 2023
Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancerKelsey Pan, Kyle Concannon, Jing Li, et al.
Expert Opinion on Investigational Drugs|January 25, 2007
Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesisRoy S Herbst, John V Heymach, Michael S O'Reilly, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2011
Targeted therapies for lung cancer: clinical experience and novel agentsJill E Larsen, Tina Cascone, David E Gerber, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2011
Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancerShervin M Shirvani, Ritsuko Komaki, John V Heymach, et al.
Pageof 141